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Abstract
Aims/hypothesis Ingested protein is a well-recognised stimu-
lus for glucagon-like peptide-1 (GLP-1) release from intestinal
L cells. This study aimed to characterise the molecular mech-
anisms employed by L cells to detect oligopeptides.
Methods GLP-1 secretion from murine primary colonic cul-
tures and Ca2+ dynamics in L cells weremonitored in response
to peptones and dipeptides. L cells were identified and puri-
fied based on their cell-specific expression of the fluorescent
protein Venus, using GLU-Venus transgenic mice.
Pharmacological tools and knockout mice were used to char-
acterise candidate sensory pathways identified by expression
analysis.
Results GLP-1 secretion was triggered by peptones and di-/
tripeptides, including the non-metabolisable glycine-sarcosine
(Gly-Sar). Two sensory mechanisms involving peptide
transporter-1 (PEPT1) and the calcium-sensing receptor
(CaSR) were distinguishable. Responses to Gly-Sar
(10 mmol/l) were abolished in the absence of extracellular
Ca2+ or by the L-type calcium-channel blocker nifedipine
(10 μmol/l) and were PEPT1-dependent, as demonstrated by
their sensitivity to pH and 4-aminomethylbenzoic acid and the
finding of impaired responses in tissue from Pept1 (also
known as Slc15a1 ) knockout mice. Peptone (5 mg/ml)-stim-
ulated Ca2+ responses were insensitive to nifedipine but were
blocked by antagonists of CaSR. Peptone-stimulated GLP-1
secretion was not impaired in mice lacking the putative
peptide-responsive receptor lysophosphatidic acid receptor 5
(LPAR5; also known as GPR92/93).
Conclusions/interpretation Oligopeptides stimulate GLP-1
secretion through PEPT1-dependent electrogenic uptake and
activation of CaSR. Both pathways are highly expressed in
native L cells, and likely contribute to the ability of ingested
protein to elevate plasma GLP-1 levels. Targeting nutrient-
sensing pathways in L cells could be used to mobilise endog-
enous GLP-1 stores in humans, and could mimic some of the
metabolic benefits of bariatric surgery.





ERK Extracellular signal-regulated kinase
Fura-2-AM Fura-2-acetoxymethyl ester
GIP Glucose-dependent insulinotropic polypeptide
GLP Glucagon-like peptide
GPRC6A G-protein-coupled receptor 6A
LPAR5 Lysophosphatidic acid receptor 5
MAPK Mitogen-activated protein kinase
PEPT Peptide transporter
PYY Peptide YY
SGLT Sodium-dependent glucose transporter
Eleftheria Diakogiannaki and Ramona Pais contributed equally to this
manuscript.
Electronic supplementary material The online version of this article
(doi:10.1007/s00125-013-3037-3) contains peer-reviewed but unedited
supplementary material, which is available to authorised users.
E. Diakogiannaki :R. Pais :G. Tolhurst :H. E. Parker :
J. Horscroft : F. M. Gribble (*) : F. Reimann (*)
Cambridge Institute for Medical Research, Wellcome Trust/MRC
Building, Addenbrooke’s Hospital, Box 139, Hills Road,
Cambridge CB2 0XY, UK
e-mail: fmg23@cam.ac.uk
e-mail: fr222@cam.ac.uk
B. Rauscher : T. Zietek :H. Daniel
Center of Life and Food Sciences Weihenstephan, Technische




Food ingestion triggers the secretion of a range of hormones
from the gastrointestinal tract that coordinate nutrient absorp-
tion, insulin secretion and appetite. The ability of the
enteroendocrine hormone glucagon-like peptide-1 (GLP-1)
to enhance glucose-dependent insulin release and suppress
appetite forms the basis for the clinical use of GLP-1 mimetics
and dipeptidyl dipeptidase 4 inhibitors for the treatment of
type 2 diabetes [1, 2]. GLP-1 levels rise dramatically after
gastric bypass, and have been implicated in the improved
insulin secretion that follows bariatric surgery [3, 4]. Such
findings have triggered renewed interest in the idea of
targeting the endogenous enteroendocrine system for the treat-
ment of diabetes and obesity.
GLP-1 is only one of a family of gut peptides involved in
the central and peripheral coordination of metabolism, acting
alongside other enteroendocrine hormones such as cholecys-
tokinin (CCK), glucose-dependent insulinotropic polypeptide
(GIP) and peptide YY (PYY). These hormones are produced
by an overlapping subset of enteroendocrine cells and are
released into the bloodstream in varying proportions follow-
ing the ingestion of carbohydrate, fat and protein. The stimu-
lation of GIP and GLP-1 release following glucose ingestion
forms the intestinal arm of the incretin axis, increasing the
responsiveness of pancreatic beta cells to the rising plasma
glucose levels. Co-ingestion of protein and fat, however,
markedly enhances glucose-triggered GLP-1 and insulin se-
cretion [5], and protein-rich meals have been associated with
elevated PYY secretion and reduced postprandial hunger
scores [6]. Understanding the mechanisms underlying
protein-sensing in the enteroendocrine system might therefore
identify strategies to increase GLP-1 release using orally
available agents.
GLP-1-producing enteroendocrine cells are classically re-
ferred to as L cells, and have been identified in the human
intestine as proximal as the duodenum. The number of L cells
and the proportion that coexpress PYY increase along the
longitudinal axis of the gastrointestinal tract [7]. Like most
enteroendocrine cells, L cells are located in the epithelial layer,
where they make direct contact with the luminal contents via
their apical projections. The mechanisms underlying L cell
carbohydrate sensing are relatively well characterised, and are
critically dependent on electrogenic sugar uptake by the
sodium-dependent glucose transporter 1 (SGLT1) [8–11].
How L cells detect ingested protein is more controversial.
We have previously reported on stimulation of GLP-1 se-
cretion from primary colonic cultures and the enteroendocrine
model cell line GLUTag by amino acids [12]. Glycine and
alanine are strong stimulants of GLUTag cells through activa-
tion of the ionotropic glycine receptor [13], but this mechanism
was not observed in colonic L cells in primary culture [8].
Glutamine, by contrast, was a strong stimulant in both the cell
line and primary intestinal cultures [14] and was subsequently
shown to stimulate GLP-1 secretion after ingestion in human
volunteers and patients with type 2 diabetes [15]. Amino-acid-
triggered secretion of GLPs has also been linked to activation
of the calcium-sensing receptor (CaSR) [16], the umami taste
receptor (Tas1R1/Tas1R3) [17] and G-protein-coupled recep-
tor 6A (GPRC6A) [18].
In the current study, we investigated if and how larger
protein fragments, such as peptones (relatively poorly defined
breakdown products of proteins after enzymatic digestion)
and oligopeptides, stimulate GLP-1 secretion in primary mu-
rine culture.
Methods
Materials and solutions Reagents were supplied by Sigma
Aldrich (Poole, UK), unless stated otherwise. The composi-
tion of standard bath solution used in all experiments was:
4.5 mmol/l KCl, 138 mmol/l NaCl, 4.2 mmol/l NaHCO3,
1.2 mmol/l NaH2PO4, 2.6 mmol/l CaCl2, 1.2 mmol/l MgCl2
and 10 mmol/l HEPES (adjusted to pH 7.4 with NaOH). For
experiments in which pH was manipulated, the pH was ad-
justed to pH 8.0 with NaOH, or for the lower pH of 6.5,
10 mmol/l PIPES was used in place of HEPES. The Ca2+-free
saline used in imaging experiments consisted of: 4.5 mmol/l
KCl, 138 mmol/l NaCl, 4.2 mmol/l NaHCO3, 1.2 mmol/l
NaH2PO4, 1.2 mmol/l MgCl2, 10 mmol/l HEPES and
0.5 mmol/l EGTA (pH 7.4). Calhex231-HCl and NPS2143-
HCl were purchased from Tocris Bioscience (Bristol, UK).
Peptone (P5905, Sigma) is an enzymatic meat hydrolysate.
Primary intestinal epithelial cell isolation and culture
Transgenic mice that express the yellow fluorescent protein
Venus driven by the proglucagon promoter were generated
using a bacterial artificial chromosome construct as previously
described [8]. All animal procedures were approved by the
local ethics committee and conformed to UK Home Office
regulations. Pept1 (also known as Slc15a1 ) knockout mice
were obtained from Deltagen (San Mateo, CA, USA) and
backcrossed for ten generations to a C57BL/6 background.
They were bred and kept in the same conditions as wild-type
C57BL/6mice in a specific pathogen-free animal facility at 22
±2°C and a 12:12 h light/dark cycle. Procedures involving
Pept1 –/– mice were performed according to the German
guidelines for animal care and approved by the state ethics
committee under reference number 55.2-1-54-2531-39-10.
Lpar5 –/– mice were generated by Takeda Cambridge
(Cambridge, UK). For generation of the targeting vectors,
homology arms were PCR amplified from genomic DNA
and cloned into a vector containing the internal ribosomal
entry site β-galactosidase reporter gene, a neomycin selection
marker and two thymidine kinase-negative selection markers.
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The linearised vector was electroporated into embryonic stem
cells (129/SvEv) and homologous recombination was detect-
ed by screening PCR and southern blot. Chimeras were gen-
erated by blastocyst injection, bred with 129/SvEv animals
and maintained inbred in this background. Homozygous ani-
mals were viable and fertile, without any obvious
abnormalities.
For tissue preparation, mice aged 3–6 months were killed
by cervical dislocation and the large intestine distal to the
caecum was excised and stored in Leibovitz L-15 medium.
The tissue was relieved of any attached tissue and luminal
dietary content, chopped finely and digested in 0.4 mg/ml
collagenase XI dissolved in DMEM (25 mmol/l glucose).
The process of tissue digestion involved four cycles of incu-
bations at 37°C followed by collection of the supernatant
fraction and replacement with fresh warm collagenase. The
supernatant fractions of the two last digests were centrifuged
for 3 min at 300 g and the pellets were resuspended in DMEM
containing 100 U/ml penicillin, 2 mmol/l L-glutamine, 10%
FBS and 0.1 mg/ml streptomycin. Cells were plated on
Matrigel (BD Bioscience, Oxford, UK) pre-coated 24-well
plastic dishes or glass-bottom culture dishes (Mattek
Ashland, MA, USA) and incubated in a humidified atmo-
sphere containing 5% CO2 at 37°C for a period ranging
between 24 h and 8 days. Cell culture media for the studies
performed on Pept1–/– mice and their littermate controls were
purchased from Invitrogen (Paisley, UK).
GLUTag cell culture The murine enteroendocrine cell lines
GLUTag and STC-1 were cultured in DMEM containing
5.6 mmol/l (GLUTag) or 25 mmol/l (STC-1) glucose
supplemented with 10% FCS (GLUTag) or 15% horse serum
and 2.5% FCS (STC-1) and 2 mmol/l L-glutamine, 100 IU/ml
penicillin and 100 μg/ml streptomycin. The cells were grown
in 75 cm2 flasks at 37°C and 5%CO2. Cultures were passaged
when they reached 70% confluence and all the experiments
were performed on cultures having undergone fewer than 30
passages.
GLP-1 secretion assay At 24 h following seeding, cells were
treated with test reagents dissolved in standard bath solution
supplemented with 0.1% fatty-acid-free BSA, for 2 h at 37°C.
Supernatant fraction and lysate samples from each well were
collected and GLP-1 was assayed using fluorescence-based
GLP-1 active (7-36) ELISA kits (Millipore, Watford, UK) or a
‘total-GLP-1’ assay (Meso Scale Discovery, Gaithersburg,
MD, USA). The results were calculated as a percentage of
the GLP-1 content (secreted plus intracellular) per well and
were normalised to the basal secretion in saline buffer mea-
sured in parallel on the same day. All conditions were tested
on two or more cultures established from one mouse each,
unless stated otherwise, and the numbers of wells investigated
are given in the figure legends.
Calcium imaging Cells were loaded with 7 μmol/l fura-2-
acetoxymethyl ester (fura-2-AM; Invitrogen) and 0.01%
pluronic acid in a standard bath solution containing
10 mmol/l glucose and 375 μmol/l eserine for 15 min at
37°C and for a further 15 min at room temperature. An
inverted fluorescence microscope (Olympus IX71, Olympus,
Southend on Sea, UK) with a ×40 oil-immersion objective
lens was used for signal visualisation. Venus was excited at
475 nm and fura-2 at 340 and 380 nm using a monochromator
(Cairn Research, Faversham, UK) and a 75W xenon arc lamp,
and emissions were recorded using an Orca ER camera
(Hamamatsu, Welwyn Garden City, UK), a dichroic mirror
and a 510 nm long pass filter. All images were collected on
MetaFluor software (Molecular Devices, Wokingham, UK).
The ratio of fura-2 emissions at 340 and 380 nm (340/380
ratio) was used to monitor changes in the intracellular calcium
concentration, while Venus fluorescence was used to identify
L cells. Solutions were perfused continuously at a rate of
approximately 1 ml/min. Mean 340/380 ratios in the presence
of the test agent were normalised to the respective mean ratio
of the background of each cell, measured before the addition
and after the washout of the test compound. Numbers (n )
given in the figure legends refer to the number of individual
cells investigated.
Quantitative RT-PCR Populations of Venus-positive cells
(L cells) or Venus-negative cells (non-L cells) of purity >95%
were separated with a MoFlo cell sorter (Beckman Coulter,
High Wycombe, UK) as previously described [8]. RNA was
extracted from FACS-sorted cells by a microscale RNA isola-
tion kit (Ambion, Austin, TX, USA) and was then reverse
transcribed to cDNA according to standard protocols. The
appropriate amount of first-strand cDNA template was mixed
with specific TaqMan primers (Applied Biosystems, Foster
City, CA, USA), water and PCR Master Mix (Applied
Biosystems), and quantitative RT-PCR was conducted using a
7900HT Fast Real-Time PCR system (Applied Biosystems).
β-Actin was used as the normalisation control. The primer/
probe pairs used in this study were from Takeda for
lysophosphatidic acid receptor 5 (Lpar5 ; also known as
Gpr92/93): forward primer: CGTCGGGCGCCATCT; reverse
primer: AGCGGTCCACGTTGATGAG; probe: FAM-
CCAGATGAACATGTACGGC-MGB; or from Applied
Biosys tems: Casr : Mm00607939_s1; GprC6A :
Mm00443375_m1; Pept1/Slc15a1 : Mm04209483_ml;
P e p t 2 / S l c 1 5 a 2 : Mm0 0 4 5 1 6 1 0 _m l ; β - a c t i n :
Mm00607939_s1. All experiments were performed on at least
three cDNAs isolated from one mouse each.
Data analysis The results are expressed as mean ± SEM.
Statistical analysis was performed using GraphPad Prism
4.01 (San Diego, CA, USA). One-way ANOVAs with post
hoc Dunnett’s or Bonferroni’s tests were performed on log-
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transformed secretion data, as these data are heteroscedastic,
and ΔCt expression data. Statistical significance for Ca
2+
imaging data was assessed by Student’s t test. Values were
regarded as significant when p <0.05.
Results
GLP-1 secretion was triggered by products of protein
digestion GLP-1 secretion from mouse colonic primary cul-
tures was dose-dependently stimulated during 2 h incubations
with an enzymatic meat hydrolysate (peptone). At the highest
tested concentration of 50 mg/ml, secretion was enhanced
approximately ninefold (Fig. 1a), while the lower peptone
concentration of 5 mg/ml peptone triggered a more modest
approximately threefold response. Synthetic di- and
tripeptides also increased GLP-1 release, although to a lesser
extent than peptone. Thus, glycine-leucine (Gly-Leu),
glycine-phenylalanine (Gly-Phe), leucine-glycine-glycine
(Leu-Gly-Gly) and the non-hydrolysable dipeptide glycine-
sarcosine (Gly-Sar) enhanced GLP-1 release by approximately
1.4-fold at a concentration of 10 mmol/l each (Fig. 1b). At the
higher concentration of 150 mmol/l (equivalent to 22 mg/ml)
Gly-Sar was less effective than peptone, increasing secretion
by approximately twofold (Fig. 1c).
Protein digestion products trigger elevation of cytoplasmic
calcium To investigate the molecular mechanisms underlying
peptone- and oligopeptide-triggered responses, cytosolic Ca2+
fluctuations were monitored in identified primary L cells in
mixed colonic cultures from GLU-Venus mice after loading
with fura-2-AM.Di-/tripeptides (10 mmol/l) and peptone (5 or
50 mg/ml) triggered calcium elevation in L cells in standard
saline buffer (Fig. 2). In Ca2+-free buffer, however, responses
to Gly-Sar and 5 mg/ml peptone were abolished, whereas
50 mg/ml peptone or bombesin remained effective (Fig. 2).
The dependence on extracellular Ca2+ for responses to dipep-
tides or 5 mg/ml peptone suggests that Ca2+ either enters
L cells across the plasma membrane or is required externally
for activation of a sensory pathway. To distinguish between
these possibilities, we tested the effect of the voltage-gated
calcium-channel blocker nifedipine. Whereas nifedipine
(10 μmol/l) abolished secretion triggered by Gly-Sar, it did
not prevent the response to 5mg/ml peptone (Fig. 3), suggesting
that these stimuli recruit distinct signalling pathways.
Expression and function of PEPTs The nifedipine sensitivity
of Gly-Sar-triggered GLP-1 secretion suggests that dipeptides
trigger a depolarisation-dependent pathway in L cells. Based
on our previous findings that the electrogenicity of brush-
border SGLTs underlies glucose sensing in enteroendocrine
cells, we investigated the expression and function of electro-
genic proton-coupled PEPT1 and PEPT2 in L cells (Fig. 4).
Pept1 expression was detected in L cells from the small
intestine and colon, as well as in non-fluorescent small intes-
tinal controls. It was low in control cells from the colon, and
barely detectable in STC-1 and GLUTag cells.Pept2 was only
poorly expressed in all the preparations examined.
PEPT1 uses inwardly directed proton gradients to drive di-
and tripeptide influx. We therefore predicted that any PEPT1-
dependent triggering mechanism would exhibit pH depen-
dence, with smaller responses occurring at high pH.
Consistent with this idea, GLP-1 secretion triggered by Gly-
Sar was greatest at pH 6.5 (1.91±0.14-fold of baseline,
p <0.001, n =14) and not significant at pH 8 (1.24±0.08-fold
of baseline, n =8; Fig. 5a). Similarly, in Ca2+ imaging experi-
ments, Gly-Sar-triggered Ca2+ responses were largely
abolished at pH 8 (Fig. 5b, c). Secretory responses to Gly-Sar
were inhibited by the non-translocated inhibitor of PEPT1,
4-aminomethylbenzoic acid (4-AMBA, 5 mmol/l; Fig. 5d)
[19]. By contrast, 4-AMBA (5 mmol/l) did not inhibit peptone
(5 or 50 mg/ml)-stimulated secretion (electronic supplementary
material [ESM] Fig. 1). Supporting a functional coupling



























































































Fig. 1 GLP-1 secretion is stimulated by oligopeptides. GLP-1 se-
cretion triggered by (a ) 0, 1, 5 and 50 mg/ml peptone (n =34, 7, 24
and 19, respectively); (b ) Gly-Sar (n =18), Leu-Gly-Gly (n =6), Gly-
Leu (n =6) or Gly-Phe (n =6) (each at 10 mmol/l); (c ) 0, 0.15, 1.5,
15 and 150 mmol/l Gly-Sar (n =27, 12, 11, 28 and 12, respectively).
In all cases, mixed primary cultures from murine colon were incu-
bated for 2 h under control conditions (standard bath solution) or in
the additional presence of oligopeptides, as indicated. GLP-1 secre-
tion in each well is expressed relative to the basal secretion (control)
measured in parallel on the same day and indicated by the dashed
line. Data represent the mean ± SEM. **p <0.01, ***p <0.001
compared with their respective controls by one-way ANOVA with
post hoc Dunnett’s test
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between PEPT1 and L cell activation, secretion was enhanced
1.4±0.1-fold above baseline (p <0.05) by the PEPT1 substrate
cefalexin (5 mmol/l; Fig. 5e). We further evaluated the role of
PEPT1 in L cell di-/tripeptide sensing using colonic cultures
from Pept1–/– mice. Basal GLP-1 release was unchanged at
approximately 4% of total GLP-1 content per 2 h in both the
wild-type and knockout groups, but secretion triggered by Gly-
Sar (20 mmol/l) was significantly impaired in cultures from the
Pept1–/– mice (Fig. 5f).
G-protein-coupled receptor candidates for peptone sensing
As LPAR5 (also known as GPR92/93) has been widely re-
ported as a candidate peptone sensor and overexpression of
LPAR5 in STC-1 cells has been linked to peptone-stimulated
CCK release [20], we initially assessed the expression profile
of this receptor and its potential involvement in GLP-1 secre-
































































































































































Fig. 2 Oligopeptide-triggered Ca2+ responses in identified L cells in
primary culture. (a , c , e) Fluorescent 340/380 ratio changes in primary
identified L cells loaded with fura-2-AM and stimulated with (a) Gly-Sar
(10mmol/l), (c) 5 mg/ml peptone or (e) 50mg/ml peptone in the presence
and absence of extracellular Ca2+ and bombesin (100 nmol/l), as indicat-
ed. (b) Mean calcium changes in L cells following the addition of Leu-
Gly-Gly (10 mmol/l, n =5), Gly-Leu (10 mmol/l, n =6), Gly-Sar
(10 mmol/l) in the presence (n=15) or absence (n =5) of extracellular
Ca2+, and bombesin in the absence of extracellular Ca2+ (Bomb,
100 nmol/l, n =5), as indicated. (d) Mean calcium changes in L cells
following the addition of peptone (Pept, 5 mg/ml) in the presence (n =14)
and absence (n =9) of extracellular Ca2+, and bombesin (Bomb,
100 nmol/l, n =9) in the absence of extracellular Ca2+, as indicated. (f)
Mean calcium changes in L cells following the addition of peptone (Pept,
50 mg/ml) in the presence (n =12) and absence (n =11) of extracellular
Ca2+, and bombesin (Bomb, 100 nmol/l, n =11) in the absence of extra-
cellular Ca2+, as indicated. (b , d , f) 340/380 ratios in the presence of the
test agent were normalised to the mean of the background ratios of each
cell measured before the addition and after washout of the test compound.
Data represent the mean ± SEM. *p <0.05, **p <0.01, ***p <0.001



































































Fig. 3 Gly-Sar- but not peptone-stimulated GLP-1 secretion relies on
activation of L-type Ca2+ channels. (a) Mixed primary cultures from
murine colon were incubated for 2 h under control conditions (standard
bath solution) with (n =9) or without (n =18) nifedipine (10 μmol/l) or in
the presence of Gly-Sar (10 mmol/l) with (n =8) or without (n =18) the
addition of nifedipine, as indicated. (b) Mixed primary cultures from
murine colon were incubated for 2 h under control conditions (standard
bath solution) with (n =6) or without (n =12) nifedipine (10 μmol/l) or in
the presence of 5 mg/ml peptone (with [n =12] and without [n =12]
nifedipine) or 50 mg/ml peptone (with [n =6] and without [n=6] nifed-
ipine), as indicated. GLP-1 secretion in each well is expressed relative to
the basal secretion (control) measured in parallel on the same day and
indicated by the dashed line. Data represent the mean ± SEM. **p <0.01,
***p <0.001 compared with their respective controls by one-way

























Fig. 4 Pept1 , but not Pept2 , is expressed in L cells. Expression of Pept1
(black bars) andPept2 (white bars) mRNA relative toβ-actin, as assessed
by RT-PCR in FACS-sorted L and non-L cells (control) from the upper
and lower small intestine (SI) and colon, and GLUTag and STC-1 model
cell lines. Data are presented as the geometric mean and upper SEM of the
2ΔCt data (n ≥3 each). Significance comparisons between L and non-L
cells were calculated byANOVAwith post hoc Bonferroni analysis on the
ΔCt data, ***p <0.001. The inset shows the data for the cell lines on an
amplified y-axis scale
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cells and control cells along the gastrointestinal tract, but
peptone- and dipeptide-triggered secretion was not impaired
in colonic cultures prepared from Lpar5–/– mice compared
with their littermate controls (Fig. 6).
An alternative candidate for peptone sensing is CaSR,
which has been implicated in amino-acid-triggered secretion
of gastrin [21], CCK [22], GIP, PYYand GLP-1 [16], and was
found by structural modelling to have a binding site large
enough to accommodate oligopeptides [23]. mRNA for
CaSR was detected in L cells isolated by flow cytometry from
the small or large intestine, while expression was lower in
non-fluorescent (non-L cell) populations and GLUTag cells
(Fig. 7a). In support of the idea that CaSR is functionally
expressed in L cells, the CaSR agonist calindol (10 μmol/l)
[24] increased GLP-1 secretion from small intestinal cultures
by 1.8±0.3-fold (n =6; p =0.02 by single-sample Student’s
t test). To evaluate the potential involvement of CaSR in


















































































































Fig. 5 PEPT1 underlies Gly-Sar-stimulated GLP-1 secretion. (a) GLP-1
secretion in response to Gly-Sar (15 mmol/l) at pH 6.5 (n =14), pH 7.4
(n =15) and pH 8.0 (n=8), as indicated. Mixed primary cultures from
murine colon were incubated for 2 h at different pHs in the presence and
absence of Gly-Sar. GLP-1 secretion in Gly-Sar-containing wells is
expressed relative to basal secretion (control) measured at the same pH
in parallel on the same day and indicated by the dashed line. Data
represent the mean ± SEM. ***p<0.001 compared with their respective
controls by one-way ANOVA with post hoc Bonferroni analysis. (b)
Fluorescent 340/380 ratio changes of a primary identified L cell loaded
with fura-2-AM and stimulated with Gly-Sar (10 mmol/l) at pH 7.4 and
8.0, as indicated. (c) Mean calcium changes in L cells following the
addition of Gly-Sar (10 mmol/l) at pH 7.4 (n =8) and 8.0 (n =8), as
indicated; 340/380 ratios in the presence of the test agent were normalised
to the mean of the background ratios of each cell measured before the
addition and after washout of the test compound. Data represent the mean
± SEM. **p <0.01, ***p<0.001 compared with baseline and between
conditions by Student’s t test. (d) GLP-1 secretion in response to Gly-Sar
(10 mmol/l) in the presence (n =9) and absence (n =9) of 4-AMBA
(5 mmol/l). (e) GLP-1 secretion in response to cefalexin (5 mmol/l,
n =7). (f ) GLP-1 secretion in the presence (black bars, n =12) and
absence (white bars, n =12) of Gly-Sar (20 mmol/l) in cultures from
wild-type and Pept1–/– mice. (d–f) Mixed primary colonic cultures were
incubated for 2 h under control conditions (standard bath solution) or in
the additional presence of the indicated agents. GLP-1 secretion in each
well is expressed relative to the basal secretion (control) measured in
parallel on the same day and indicated by the dashed line. Data represent
the mean ± SEM. *p <0.05, **p <0.01, ***p <0.001 compared with their
respective controls by Student’s t test (e) or one-way ANOVAwith post






















































Fig. 6 Peptone-stimulated GLP-1 secretion is not dependent on LPAR5.
(a) Expression of Lpar5 mRNA relative to β-actin assessed by RT-PCR
in FACS-sorted L cells (black bars) and non-L cells (white bars, control)
from the upper and lower small intestine (SI) and colon, and the GLUTag
model cell line. Data are presented as the geometric mean and upper SEM
of the 2ΔCt data. No significant differences between L and non-L cells
were observed by ANOVA of the ΔCt data (n ≥3 each). (b) Mixed
primary cultures from murine colon isolated from wild-type controls
(white bars) or Lpar5–/– animals (black bars) were incubated for 2 h
under control conditions (standard bath solution, n =14) or in the addi-
tional presence of Gly-Sar (150 mmol/l, n =8), 5 mg/ml peptone (n =14),
50 mg/ml peptone (n =14) or glucose plus forskolin (Fsk) and
isobutylmethylxanthine (IBMX; 10 mmol/l, 10 μmol/l and 10 μmol/l,
respectively; Fsk/IBMX, n =14), as indicated. GLP-1 secretion in each
well is expressed relative to the basal secretion (control) measured in
parallel on the same day and indicated by the dashed line. Data represent
the mean ± SEM. ***p<0.001 compared with their respective controls
by one-way ANOVA with post hoc Bonferroni analysis. No significant
difference between genotypes was observed
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Calhex231, selective Ca2+-sensing receptor antagonists [25,
26]. NPS2143 (5 μmol/l) and Calhex231 (10 μmol/l) both
significantly lowered peptone-triggered GLP-1 secretion from
primary colonic cultures (Fig. 7b).
Discussion
There is considerable debate about the mechanisms by which
enteroendocrine cells detect protein ingestion. A number of
receptors and transporters have been identified that may under-
lie sensitivity to amino acids, but data suggest that larger di-, tri-
and oligopeptides also stimulate release of hormones such as
CCK and GLP-1. Our findings implicate CaSR and PEPT1 as
sensors for these larger protein digestion products in primary L
cells. Both pathways are sensitive to external calcium: CaSR
because it requires Ca2+ binding to the extracellular Venus
flytrap domain, and PEPT1 because it triggers membrane
depolarisation and subsequent opening of voltage-gated Ca2+
currents. Interestingly, GLUTag cells, which have barely de-
tectable expression of Casr and Pept1 , were not activated by
Gly-Sar and did not exhibit a greater secretory response to
peptone than to glutamine alone (ESM Fig. 2).
CaSR has previously been implicated in amino acid (espe-
cially phenylalanine)-triggered secretion of gastrin [21], CCK
[22], GIP, PYY and GLP-1 [16]. Structural studies, however,
suggest that CaSR could also bind di-, tri- and oligopeptides
[23]. Our data show that Casr was highly and specifically
expressed in primary L cells, that Ca2+ responses to 5 mg/ml
peptone in L cells were abolished by removal of extracellular
Ca2+ and that peptone-triggered GLP-1 secretion was sensi-
tive to the CaSR antagonists NPS2143 and Calhex231. The
related receptor, GPRC6A, was recently demonstrated to un-
derlie ornithine-stimulated GLP-1 secretion from GLUTag
cells [18], but our data indicate that the cell line expresses
relatively higher levels of Gprc6a and lower levels of Casr
than primary L cells. Consistent with this observation,
calindol, which inhibits GPRC6A but stimulates CaSR sig-
nalling [24], increased rather than decreased GLP-1 secretion
from primary intestinal cultures.
Contrary to the Ca2+ responsiveness of Gly-Sar and 5 mg/
ml peptone, the higher peptone concentration of 50 mg/ml
peptone elicited a Ca2+ response in Ca2+-free medium. This is
close to the solubility limit of peptone, and may trigger non-
specific pathways. Our data show, however, that the secretory
response is unlikely to represent an osmolar artefact, as
150 mmol/l Gly-Sar did not mimic the response, and also
does not involve LPAR5, as knockout of this receptor had
no effect on GLP-1 secretion triggered by low- or high-
concentration peptone.
Meat hydrolysate has previously been shown to stimulate
GLP-1 secretion in vascularly perfused rat jejunum/ileum,
STC-1 cells [27] and the human GLP-1-secreting NCI-H716
cell line [28]. In the last of these, it was linked to activation of
extracellular signal-regulated kinase (ERK)1/2, as demon-
strated by the inhibitory effect of U0126 – a blocker of
mitogen-activated protein kinase kinase (MEK)1/2. CaSR,
which is known also to couple to mitogen-activated protein
kinase (MAPK) and ERK1/2 in some cell types [29], may
provide an underlying basis for these observations. Although
meat hydrolysate triggered ERK phosphorylation in NCI-
H716 cells within 2–15 min, this was not sufficient to trigger
GLP-1 release as other activators of ERK, such as epidermal
or fibroblast growth factor, did not enhance GLP-1 secretion
[30]. These data suggest the existence of additional pathways
that synergise with the ERK1/2–MAPK pathway.
The nifedipine sensitivity of Gly-Sar-triggered GLP-1 re-
lease from primary cultures suggests the recruitment of path-
ways dependent upon membrane depolarisation, which our































































Fig. 7 Role of CaSR in peptone-stimulated GLP-1 secretion. (a) Casr
expression in L cells: expression of Casr mRNA relative to β-actin
assessed by RT-PCR in FACS-sorted L cells (black bars) and non-L cells
(white bars, control) from the upper and lower small intestine (SI) and
colon, and GLUTag cells. Data are presented as the geometric mean and
upper SEM of the 2ΔCt data, calculated from ΔCt values (n ≥3 each).
Significance comparisons between L and non-L cells were calculated by
ANOVAwith post hoc Bonferroni’s test on the ΔCt data, ***p <0.001.
(b) Casr inhibition ameliorates peptone-stimulated GLP-1 secretion:
mixed primary cultures from murine colon were incubated for 2 h under
control conditions (standard bath solution, n=19) or in the additional
presence of Calhex231 (10 μmol/l, n=6), NPS2143 (5 μmol/l, n =5) and/
or peptone (5 mg/ml) (n =13 without other addition, n =6 with
Calhex231, n=10 with NPS2143), as indicated. GLP-1 secretion in each
well is expressed relative to the basal secretion (control) measured in
parallel on the same day and indicated by the dashed line. Data represent
themean ± SEM. **p <0.01, ***p <0.001 comparedwith their respective
controls by one-way ANOVAwith post hoc Bonferroni analysis
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PEPT1. PEPT1 is a brush-border transporter of di- and
tripeptides and is also responsible for uptake of peptide-based
drugs such as the cephalosporin family of antibiotics [31]. The
idea that electrogenic H+-coupled influx of dipeptides by
PEPT1 could act as a trigger for GLP-1 release arose from
our previous reports that luminal sugar sensing by L cells is
directly linked to Na+-coupled glucose uptake by SGLT1, and
that glutamine similarly triggers Ca2+ elevation in L cells via
Na+-coupled amino acid transport [12, 32]. A PEPT1-
dependent dipeptide-sensing pathway has been difficult to
demonstrate using the cell line models GLUTag and STC-1,
because they express endogenous Pept1 only very poorly
compared with native L cells, although transfection of STC-1
cells with Pept1 has been reported to confer responsiveness to
peptides [33]. In primary L cells, by contrast, we observed
responses to the non-metabolisable PEPT1 substrate Gly-Sar
that were pH-dependent, blocked by the competitive antagonist
4-AMBA and significantly reduced in Pept1 knockout mice.
Taken together with the sensitivity of Gly-Sar-triggered GLP-1
release to nifedipine, our data are consistent with the idea that
the depolarising effect of H+-dependent peptide uptake in L
cells leads to GLP-1 secretion through increased electrical
activity. The apical localisation of PEPT1, like several other
electrogenic transporters, provides an explanation for how
enteroendocrine cells can distinguish between luminal and
basolateral nutrient supplies [34].
Conclusion Nutritional effects on the gut endocrine sys-
tem are critical for the coordinated digestion, absorption
and peripheral disposal of ingested food, and the regula-
tion of appetite. Increased nutrient delivery to the lower
gut following gastric bypass surgery triggers dramatically
elevated postprandial GLP-1 levels, contributing to im-
proved beta cell function and resolution of many cases of
type 2 diabetes [3]. Harnessing the endogenous secretory
capability of the enteroendocrine system is a strategy
currently under development for the treatment of diabetes
and obesity, aiming to mimic the beneficial effects of
bariatric surgery. As colonic expression of both Pept1
and Casr is relatively specific for L cells, and activation
of both clearly stimulates hormone secretion, these path-
ways might offer exploitable targets for the mobilisation
of intestinal GLP-1 and PYY.
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